GLP-1 receptor agonists have been shown to reduce systemic inflammation through several mechanisms: Reducing oxidative stress: GLP-1s can reduce oxidative stress, a key contributor to inflammation
Many people regain weight when they stop taking them, which is why patients should think carefully about whether they are ready for long-term treatment, at least until we have better evidence on how to maintain weight loss after stopping medication or treatments that more durably change the course of obesity
Both albiglutide and dulaglutide received FDA approval for the treatment of T2DM in 2014, with dulaglutide having an additional indication since 2020 to reduce the risk of major adverse cardiovascular events (MACE) in adults with T2DM and established cardiovascular disease or multiple cardiovascular risk factors [ Table 2 ]
Osteoarthritis Relief: Patients reported an average 75.8% reduction in knee pain , with many becoming entirely pain-free due to the combination of rapid weight loss and reduced inflammation
Burns offers customized post-weight-loss body contouring plans using the latest technologies, including Renuvion, to help patients look as good as they feel
Weight regain after stopping Clinical data for tirzepatide shows significant weight regain after discontinuation